Scientists from Russia and the United States have proposed new material for regenerative medicine. The compounds in the composition of this material literally “turn off” the work of enzymes that are responsible for the inflammation reaction that occurs in immune cells in response to external stimuli. The results of the researchers’ work are published in the journal ACS Biomaterials Science & Engineering.
“At the moment, researchers do not have a lot of tools to regulate the immune response in the arsenal. Continue reading